New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 18, 2012
22:37 EDTRMBS, ACTG, RPXCRegulators to study impact of patent firms on technology competition, WSJ say
The Justice Department and its fellow antitrust enforcer, the Federal Trade Commission, are trying to better understand the impact of specialized patent-holding firms, or "trolls" to their critics, on competition in the technology market, says the Wall Street Journal. Reference Link
News For RPXC;ACTG;RMBS From The Last 14 Days
Check below for free stories on RPXC;ACTG;RMBS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 22, 2014
10:02 EDTRMBSRambus falls after earnings and guidance, levels to watch
Subscribe for More Information
09:00 EDTRMBSRambus falls 7.3%
Subscribe for More Information
April 21, 2014
19:02 EDTRMBSOn The Fly: After Hours Movers
NOTABLE: Allergan (AGN), up 20%, and Valeant Pharmaceuticals (VRX), up 9.1%, both advanced after The Wall Street Journal reported that activist investor Bill Ackman is teaming up with Valeant to make a bid for Allergan. Following the report, Ackman's Pershing Square filed a 13D with the SEC disclosing a 9.7% stake in Allergan and outlining an agreement with Valeant. The agreement, among other things, said that Valeant plans to make a bid for Allergan comprised of $15B of cash and a to-be-determined amount of Valeant stock. The filing also showed that Ackman began building a position in Allergan in late February, and at that time entered an agreement with Valeant forming a new, jointly-owned entity through which to acquire a position in Allergan. CNBC's David Faber reported that Valeant is expected to officially make a hostile bid for Allergan by tomorrow. UP AFTER EARNINGS: Netflix (NFLX) gained 6.3% after reporting profits that beat expectations on revenues that were in-line with expectations. The streaming internet video service also reported that U.S. subscribers grew by 2.25M in the first quarter, with its international subscriber base expanding by 1.75M for the period. DOWN AFTER EARNINGS: Rambus (RMBS) fell 7.5% after providing a second quarter revenue outlook that fell short of expectations, with the company adding that its revenue outlook, "includes expectations that the company will sign new customers for patent as well as solutions licensing." Rambus' first quarter results, however, came in better than expected, and the company also reaffirmed its fiscal 2014 revenue outlook.
17:21 EDTRMBSRambus reaffirms FY14 revenue $295M-$305M, consensus $298.75M
Subscribe for More Information
16:49 EDTRMBSRambus lower by 10% after providing Q2 revenue guidance
Subscribe for More Information
16:12 EDTRMBSRambus sees Q2 revenue $69M-$74M, consensus $74.48M
16:11 EDTRMBSRambus reports Q1 adjusted EPS 17c, consensus 3c
Subscribe for More Information
15:16 EDTRMBSNotable companies reporting after market close
Subscribe for More Information
09:21 EDTACTGOn The Fly: Pre-Market Movers
HIGHER: Sarepta (SRPT), up 54% after announcing plans to to submit NDA for Eteplirsen by year end 2014. Shares of Prosnesa (RNA), another drugmaker working on a competing DMD drug, are up more than 12%... AstraZeneca (AZN), up 6% after the Sunday Times says that Pfizer (PFE) is considering a takeover bid for the company. Pfizer is up 1.2% following the report... Newmont Mining (NEM), up 8% after WSJ says the company and Barrick Gold (ABX) could resume merger talks as soon as today... Cbeyond (CBEY), up 39% after agreeing to be acquired for about $323M by Birch Communications... Momenta Pharma (MNTA), up 10.5% after the Supreme Court rejected Teva's (TEVA) bid to delay generic Copaxone... Nu Skin (NUS), up 5% after saying its China division will resume corporate-hosted business meetings... Micron (MU), up 4% after price target raised at Drexel Hamilton... DOWN AFTER EARNINGS: Acacia Research (ACTG), down 6%... athenahealth (ATHN), down 5.6%.
09:00 EDTACTGAcacia Research falls 7.6%
Subscribe for More Information
April 17, 2014
16:02 EDTACTGAcacia Research reports Q1 adjusted EPS (11c), may not compare consensus 4c
Subscribe for More Information
15:29 EDTACTGNotable companies reporting after market close
Notable companies reporting before tomorrow's market open, with earnings consensus, include athenahealth (ATHN), consensus 17c; Allison Transmission (ALSN), consensus 31c; Investors Bancorp (ISBC), consensus 24c; Cepheid (CPHD), consensus (17c); Advanced Micro Devices (AMD), consensus 0c; Associated Banc-Corp (ASBC), consensus 25c; Hub Group (HUBG), consensus 36c; Capital Bank (CBF), consensus 24c; Select Comfort (SCSS), consensus 32c; Acacia Research (ACTG), consensus 4c.
April 16, 2014
06:03 EDTACTGAcacia Research subsidiary signs patent license agreement with Samsung
Acacia Research's Saint Lawrence Communications subsidiary has entered into a settlement and patent license agreement with Samsung Electronics. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.
April 15, 2014
06:06 EDTACTGAcacia Research's subsidiary partners with semiconductor company
Subscribe for More Information
April 11, 2014
06:58 EDTRMBSRambus initiated with a Buy at Benchmark Co.
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use